文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外膜肺氧合治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征:一项多中心描述性研究

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在重症新冠病毒肺炎相关重度ARDS接受机械通气的患者中,接受ECMO者病死率57.1%,与未接受ECMO者63.2%相比无显著差异;上机前严重二氧化碳潴留和酸中毒提示预后不良。

该描述性研究纳入武汉两家定点医院ICU在2020年1月8日至3月31日收治的129例重症新冠病毒肺炎患者,其中59例接受机械通气,21例接受ECMO支持。与未接受ECMO的机械通气患者相比,ECMO组病死率有下降趋势但无统计学差异(24/38[63.2%] vs 12/21[57.1%],p=0.782)。截至2020年4月7日,ECMO组12例死亡、9例存活。ECMO患者中,存活者上机前PaCO2低于死亡者(54.40 mm Hg[29.20-57.50 mm Hg] vs 63.20 mm Hg[55.40-72.12 mm Hg],p=0.006),pH高于死亡者(7.38[7.28-7.48] vs 7.23[7.16-7.33],p=0.023)。作者认为ECMO可能是重症新冠病毒肺炎相关重度ARDS的有效挽救治疗,上机前严重CO2潴留和酸中毒提示预后不良。

要点

  • ECMO组病死率12/21(57.1%),未接受ECMO的机械通气组24/38(63.2%),两组比较p=0.782,差异无统计学意义。
  • ECMO患者中存活者上机前PaCO2为54.40 mm Hg(29.20-57.50 mm Hg),死亡者为63.20 mm Hg(55.40-72.12 mm Hg),p=0.006。
  • ECMO患者中存活者上机前pH为7.38(7.28-7.48),死亡者为7.23(7.16-7.33),p=0.023。
  • 截至2020年4月7日,21例接受ECMO的患者中12例死亡、9例存活。
  • 作者认为ECMO可能是重症新冠病毒肺炎相关重度ARDS的有效挽救治疗,上机前严重CO2潴留和酸中毒提示预后不良。

适用人群与场景

  • 2020年1月8日至3月31日武汉大学中南医院和武汉市肺科医院ICU收治的129例重症新冠病毒肺炎患者。
  • 其中59例接受机械通气,21例接受ECMO支持(中南医院14例,武汉市肺科医院7例)。

红旗征与不能漏的情况

  • ECMO患者上机前严重CO2潴留和酸中毒提示预后不良:死亡者上机前PaCO2为63.20 mm Hg(55.40-72.12 mm Hg),存活者为54.40 mm Hg(29.20-57.50 mm Hg),p=0.006。
  • ECMO患者上机前pH死亡者为7.23(7.16-7.33),存活者为7.38(7.28-7.48),p=0.023。

研究设计与关键结果

  • 研究类型:描述性研究,来自两家医院。
  • 研究对象:2020年1月8日至3月31日两家医院ICU收治的129例重症新冠病毒肺炎患者,其中59例接受机械通气,21例接受ECMO支持。
  • 主要结果:ECMO组病死率12/21(57.1%),未接受ECMO的机械通气组24/38(63.2%),两组比较p=0.782,差异无统计学意义。
  • ECMO患者转归:截至2020年4月7日,21例中12例死亡、9例存活。
  • ECMO患者上机前指标:存活者PaCO2为54.40 mm Hg(29.20-57.50 mm Hg),死亡者为63.20 mm Hg(55.40-72.12 mm Hg),p=0.006;存活者pH为7.38(7.28-7.48),死亡者为7.23(7.16-7.33),p=0.023。

证据类型、等级与局限

  • 证据类型:描述性研究(来自两家医院)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ECMO可能是重症新冠病毒肺炎相关重度ARDS的有效挽救治疗。
  • 作者认为上机前严重CO2潴留和酸中毒提示预后不良。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Severe acute respiratory distress syndrome is complicated with coronavirus disease 2019 and extracorporeal membrane oxygenation support may be necessary in severe cases. This study is to summarize the clinical features, extracorporeal membrane oxygenation characteristics, and outcomes of patients with severe acute respiratory syndrome coronavirus 2 pneumonia received extracorporeal membrane oxygenation.

DESIGN: Descriptive study from two hospitals.

SETTING: The ICUs from university hospitals.

PATIENTS: Patients with severe acute respiratory syndrome coronavirus 2 pneumonia received mechanical ventilation, including those underwent extracorporeal membrane oxygenation from Zhongnan Hospital of Wuhan University and Wuhan Pulmonary Hospital from January 8, 2020, to March 31, 2020.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Clinical records, laboratory results, ventilator parameters, and extracorporeal membrane oxygenation-related data were abstracted from the medical records. One-hundred twenty-nine critically ill patients with severe acute respiratory syndrome coronavirus 2 pneumonia were admitted to ICU of the two referral hospitals. Fifty-nine patients received mechanical ventilation and 21 of them received extracorporeal membrane oxygenation support (fourteen from Zhongnan hospital and seven from Wuhan pulmonary hospital). Compared to mechanical ventilation patients without extracorporeal membrane oxygenation support, there was a tendency of decline in mortality but with no significant difference (no-extracorporeal membrane oxygenation group 24/38 [63.2%] vs extracorporeal membrane oxygenation group 12/21 [57.1%]; p = 0.782). For those patients with extracorporeal membrane oxygenation, 12 patients died and nine survived by April 7, 2020. Among extracorporeal membrane oxygenation patients, the PaCO2 prior to extracorporeal membrane oxygenation was lower (54.40 mm Hg [29.20-57.50 mm Hg] vs 63.20 mm Hg [55.40-72.12 mm Hg]; p = 0.006), and pH prior to extracorporeal membrane oxygenation was higher (7.38 [7.28-7.48] vs 7.23 [7.16-7.33]; p = 0.023) in survivors than nonsurvivors.

CONCLUSIONS: Extracorporeal membrane oxygenation might be an effective salvage treatment for patients with severe acute respiratory syndrome coronavirus 2 pneumonia associated with severe acute respiratory distress syndrome. Severe CO2 retention and acidosis prior to extracorporeal membrane oxygenation indicated a poor prognosis.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Yang X, Cai S, Luo Y, et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study. Crit Care Med. 2020. PMID: 32427613. doi:10.1097/CCM.0000000000004447

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。